Testosterone Concentration in Young Patients With Diabetes

  1. Anil Chandel, MD,
  2. Sandeep Dhindsa, MD,
  3. Shehzad Topiwala, MD,
  4. Ajay Chaudhuri, MD and
  5. Paresh Dandona, MD, PHD
  1. From the Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Buffalo, New York; and Kaleida Health, Buffalo, New York
  1. Corresponding author: Paresh Dandona, pdandona{at}KaleidaHealth.org

Abstract

OBJECTIVE—We have previously shown that hypogonadotrophic hypogonadism is common in middle-aged patients with type 2, but not with type 1, diabetes. We have now investigated the total and free testosterone concentrations in young (aged 18–35 years) type 1 and type 2 diabetic patients.

RESEARCH DESIGN AND METHODS—In this study carried out in a tertiary referral center, serum concentrations of total and free testosterone were measured in 38 type 1 diabetic (mean age 26.45 ± 0.89 years) and 24 type 2 diabetic (mean age 27.87 ± 0.97 years) subjects. The mean BMI of type 1 and type 2 diabetic patients was 27.41 ± 1.18 and 38.55 ± 2.04 kg/m2, respectively (P < 0.001).

RESULTS—The mean total testosterone concentration of type 1 and type 2 diabetic patients was 22.89 ± 1.23 and 11.14 ± 0.99 nmol/l, respectively (P < 0.001). The mean free testosterone concentration of type 1 and type 2 diabetic patients was 0.489 ± 0.030 and 0.296 ± 0.022 nmol/l, respectively (P < 0.001). Eight of 24 (33%) type 2 diabetic patients had subnormal free testosterone concentrations (<0.225 nmol/l). Using an age-based reference range, 14 of 24 (58%) type 2 diabetic patients had low free testosterone concentrations (<0.278 nmol/l). Three of 38 (8%) type 1 diabetic patients had free testosterone concentrations below the lower limit of normal (P = 0.02 when compared with type 2 diabetes). Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) concentrations in type 2 diabetic patients with low free testosterone concentrations were in the normal range and were similar to those in type 1 diabetic patients.

CONCLUSIONS—Young type 2 diabetic patients have significantly lower plasma concentrations of total and free testosterone and inappropriately low LH and FSH concentrations with a very high prevalence of hypogonadotrophic hypogonadism, when compared with type 1 diabetic patients of a comparable age. The potential implications for their sexual and reproductive function during prime reproductive years are profound.

Footnotes

  • Published ahead of print at http://care.diabetesjournals.org on 23 July 2008.

    Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.

    • Accepted July 13, 2008.
    • Received May 6, 2008.
« Previous | Next Article »Table of Contents

This Article

  1. Published online before print July 23, 2008, doi: 10.2337/dc08-0851 Diabetes Care October 2008 vol. 31 no. 10 2013-2017
  1. » Abstract
  2. Full Text
  3. Full Text (PDF)
  4. All Versions of this Article:
    1. dc08-0851v1
    2. 31/10/2013 most recent

Current Issue

  1. December 2009, 32 (12)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care